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Because of their central role in regulation of cellular function, structure/function relationships for G-protein coupled receptors (GPCR) are of
vital importance, yet only recently have sufficient data been obtained to begin mapping those relationships. GPCRs regulate a wide range of
cellular processes, including the senses of taste, smell, and vision, and control a myriad of intracellular signaling systems in response to external
stimuli. Many diseases are linked to GPCRs. A critical need exists for structural information to inform studies on mechanism of receptor action
and regulation. X-ray crystal structures of only one GPCR, in an inactive state, have been obtained to date. However considerable structural
information for a variety of GPCRs has been obtained using non-crystallographic approaches. This review begins with a review of the very earliest
GPCR structural information, mostly derived from rhodopsin. Because of the difficulty in crystallizing GPCRs for X-ray crystallography, the
extensive published work utilizing alternative approaches to GPCR structure is reviewed, including determination of three-dimensional structure
from sparse constraints. The available X-ray crystallographic analyses on bovine rhodopsin are reviewed as the only available high-resolution
structures for any GPCR. Structural information available on ligand binding to several receptors is included. The limited information on excited
states of receptors is also reviewed. It is concluded that while considerable basic structural information has been obtained, more data are needed to
describe the molecular mechanism of activation of a GPCR.
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G-protein coupled receptors (GPCR) function at the heart of
inter- and intra-cellular regulation. These transmembrane pro-
teins interact with extracellular signals, usually through the
binding of small signaling molecules. This ligand binding
induces a change in conformation of the receptor that is trans-
mitted to the cytoplasmic face of the protein, enabling a coupling
of the cytoplasmic face with an intracellular heterotrimeric G
protein (GTP binding protein). The intracellular G protein, in
turn, acts as an intracellular signal by activating or inhibiting
intracellular enzymes. This model of cellular communication
became so successful through evolution that GPCRs are used to
enable the senses of taste, smell, and vision, and to control a
myriad of intracellular signaling systems. Nearly 1000 such
receptors are thought to be present in the human genome [1].
Diseases such as some forms of blindness, obesity, inflamma-
tion, depression, and hypertension, among others, can be linked
to malfunctions of GPCRs [2]. Not surprisingly, about half of
drug targets in the pharmaceutical industry are GPCRs [3].
The power of structure to inform studies on function has
been well demonstrated in many systems. Therefore it is no
surprise that enormous effort has been expended to obtain
structural information for GPCRs. Yet, to date, X-ray crystal-
lography has provided information on only one GPCR, bovine
rhodopsin. The dearth of crystallography on GPCRs is a result
of the problems that beset structural studies on all integral
membrane proteins: such proteins are insoluble in water and
cannot be readily crystallized. Furthermore, nuclear magnetic
resonance (NMR) studies on intact membrane proteins are
problematic due to the size of the requisite protein-detergent
micelle and the influence of the relatively slow rotational
correlation time on the relaxation properties.
Therefore in this review, the X-ray crystal structure of
rhodopsin will be discussed, but much of the review will
address alternate approaches to structure of GPCRs because for
all GPCRs other than rhodopsin, no crystal structures are
available and the alternate approaches are the only path to
structural information.
2. Early structural information on rhodopsin
Rhodopsin was the first GPCR to be studied in detail. The
ability to isolate rhodopsin in milligram quantities from bovineretinas enabled a wide variety of biochemical and structural
experiments well before studies on other GPCRs commenced,
in fact before it was known that rhodopsin was a member of the
superfamily of GPCRs. While it has been known for a long time
that GPCRs are built around a bundle of 7 transmembrane
helices, it is valuable to understand from what experiments this
knowledge was first derived.
Circular dichroism (CD) experiments in the 1960s and 1970s
were widely used to investigate secondary structure in soluble
proteins. These optically active transitions were shown to be
sensitive to the presence of α-helix, β-sheet, etc., in the protein
structure. Consequently, CD was also used to explore
membrane protein structure. For example, the secondary
structure of human erythrocyte glycophorin was examined
with CD, both by CD measurements on the intact protein and by
CD measurements on proteolytic fragments of glycophorin. Not
only did the data show that the transmembrane segment of this
protein was α-helical, but these experiments also revealed a
domain structure in this membrane protein: the fragments of the
protein retained the secondary structure characteristic of the
intact protein [4]. This domain property of membrane proteins
has been exploited in structural studies of GPCRs, as will
become apparent later.
CD studies on rhodopsin from the University of Virginia in
1978 were the first to provide quantitative evidence for a
transmembrane helical bundle as an architectural feature of this
GPCR. CD studies on rhodopsin in rod outer segment disks and
purified rhodopsin in octyl glucoside micelles indicated a
largely α-helical structure. When the α-helical content was
analyzed, the α-helical content was consistent with about 7–9
transmembrane helical segments [5]. Combining this with a
knowledge that the amino terminal and the carboxyl terminal
were on opposite sides of the membrane [6] led to the initial
suggestion that rhodopsin was built on a bundle of 7
transmembrane helices.
The next major step in the search for rhodopsin structure was
the publication from Moscow and from the University of
Southern Illinois in 1982–83 of the primary sequence of
rhodopsin [7,8] from chemical sequencing experiments. This
represented a much larger challenge in that time than
sequencing membrane proteins presents today since in the
intervening period the ability to sequence from the DNA
became feasible. With the primary sequence in hand, a
hydropathy plot could be obtained of the protein. Such a plot
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hydropathy plot shows six clear hydrophobic transmembrane
segments. The hydropathy plot is not as clear for the seventh
transmembrane segment because of the presence of the lysine in
the middle of that segment.
It was 10 years before the next major breakthrough occurred
in the search for the first structure of a GPCR, rhodopsin. Two-
dimensional crystals of dark-adapted bovine rhodopsin were
obtained at the University of Cambridge in 1993. Cryo-electron
microscopy from tilted specimens yielded a low resolution two-
dimensional projection map of rhodopsin in phospholipid
bilayers [9]. In these maps one could see unequivocally the
bundle of seven transmembrane helices that are now believed to
characterize the structure of all GPCRs (see for example [10]).
An expanded set of data were subsequently utilized to obtain
limited projections in a third dimension, revealing for the first
time the overall shape of the rhodopsin molecule [11]. Many,
but not all, of the transmembrane helices were seen to lie
approximately perpendicular to the membrane surface.
In 2000, the first three dimensional crystals of bovine
rhodopsin were obtained [12]. These quickly led to a three
dimensional high resolution structure for this GPCR, which for
the first time provided a sufficiently detailed view that the
disposition of the retinal in the structure could be determined
[13]. This review will return to further discussion of these and
other landmark reports that have provided a detailed view of the
structure of bovine rhodopsin, still the only GPCR for which
high-resolution structures are available.
3. Alternative approaches to GPCR structure—studies of
fragments
The path to a three dimensional structure of rhodopsin was
long and difficult. To date, no other X-ray crystal structures of
GPCRs have been published. The difficulty arises from the
inherent problems with crystallization of membrane proteins.
Membrane proteins must be isolated in detergents because of
the substantial portion of the protein surface that is hydrophobic
(the transmembrane domain), and the detergents in a sense
constitute an “impurity”which inhibits crystallization generally.
Furthermore for many membrane proteins much of the proteinFig. 1. Hydropathy plot for rhodopsin, using http://www.vivo.colostate.edu/
molkit/hydropathy/index.html.surface is covered by the detergent prohibiting the kinds of
protein–protein contacts characteristic of three-dimensional
crystals. The magnitude of the difficulty posed by these and
other factors is manifested by less than 0.5% of the entries in the
Protein Data Bank that report structures of membrane proteins.
The other major tool for determination of high-resolution
structures is NMR. While this approach has been very
successful for soluble proteins, only a few structures of
membrane proteins have been obtained by NMR. These are
the porins from bacteria, which are β-barrels. No structures
have yet been obtained for proteins built around bundles of
transmembrane helices. The reasons are several-fold. Since
membrane proteins must be purified in detergents, it is a
complex of detergents and protein that must be studied. The
complex is large, effectively many 10s of kDa, and the
rotational correlation time of such a complex is long relative
to many soluble proteins, leading to unfavorable T2 relaxation
and broad overlapping resonances. While new techniques offer
a partial solution [14], another problem intervenes. Deuteration
is required to help defeat the relaxation problems, and is
achieved, in part, by expressing the protein in a system
containing D2O. This leads to deuteration of key-NH on the
polypeptide backbone, which must be exchanged for hydrogen,
1H. The β-barrels of the porins can be sufficiently unfolded to
permit exchange while allowing refolding to the native
configuration. However, reversible unfolding of the α-helices
of transmembrane proteins in detergents sufficient to permit
hydrogen exchange as well as refolding to the native structure is
problematic.
Therefore alternative approaches to the structures of GPCRs
are, and will continue to be, essential. One very useful approach
is the study of suitably chosen fragments of membrane proteins.
For example, biochemical experiments demonstrated that
peptide fragments from the cytoplasmic face of the GPCR,
rhodopsin, inhibited the interaction of rhodopsin with its G
protein, transducin [15]. This observation was the inspiration
for a study of one such peptide fragment by solution NMR. The
rationale was that if the peptide fragment of the receptor had
such biological activity, and if the peptide fragment also was
structured in solution, then the solution structure was likely
relevant to the structure of the native protein. In fact, the first
such NMR study in 1995 discovered that one of those rhodopsin
peptides with biological activity was structured in solution,
initially revealed by CD measurements, and subsequently
defined in detail by high resolution solution NMR techniques
[16].
CD was also the method of choice for an early study of
fragments of the avian and mammalian β-adrenergic receptors.
The investigators reported that fragments of the third cytoplas-
mic loop interacted with membranes and adopted increased
helicity when bound [17].
These observations was quickly followed by an NMR study
of a peptide fragment from the cytoplasmic face of another
receptor, the G-protein coupled parathyroid hormone/parathyr-
oid hormone related protein receptor, which also proved to be
structured in solution [18]. In the same time period, a peptide
corresponding to the seventh transmembrane domain of the
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solution NMR. While no biological activity was ascribed to this
segment to link it with the intact receptor, the structure obtained
was helical [19], which proved to be completely consistent with
the subsequent structural work. These studies opened a new
field of research in which fragments of GPCRs were
synthesized or expressed and their structures determined by
solution NMR techniques. This approach has offered the widest
range of structural information on GPCRs to date and will be
reviewed in the following, organized by receptor.
3.1. Angiotensin II AT1A receptor
The rat angiotensin II AT1A receptor is a GPCR. The third
cytoplasmic loop, the first extracellular loop and a portion of the
carboxyl terminus of this receptor have been studied as peptides
in solution with NMR. A peptide fragment, corresponding to
residues 300 to 320 of the whole receptor, was studied by
solution NMR. The data showed that part of this fragment
formed an amphipathic helix [20]. The X-ray crystal structure of
rhodopsin suggested that this amphipathic helix likely corre-
sponded to what is now called helix 8 which may be involved in
binding to the G protein [21]. Two peptides were synthesized
that spanned the third cytoplasmic loop of this receptor [22].
While only modest structure was observed in these fragments,
nevertheless some helix was observed. While in one of the
peptides the helix likely reflects an extension of the transmem-
brane helices of the receptor, helix in the other peptide most
likely represents a helical region involved in binding to the G
protein [23]. The fragment peptide corresponding to the first
extracellular loop forms a type 2 β turn [24] which is stabilized
by the presence of membranes [25]. As will be seen in this
section, many of the small turns of these GPCRs (connecting
two transmembrane helices) are stable as turns separate from the
remainder of the protein. This observation is consistent with
calorimetric experiments that demonstrate a modest contribu-
tion to overall protein stability from the loops of integral
membrane proteins consisting of transmembrane helical
bundles [26].
3.2. Parathyroid hormone receptor
Fragments of the parathyroid hormone receptor, a GPCR,
have been studied by solution NMR techniques in detergent
micelles. A peptide corresponding to the third cytoplasmic loop
of this receptor was synthesized and the NMR solution structure
determined in sodium dodecylsulfate (SDS) micelles and in
dodecylphosphocholine (DPC) micelles. As a part of the pattern
referred to above with fragments corresponding to loops on the
face of GPCRs, the peptide corresponding to the loop region
formed a loop structure in the presence of detergent micelles and
in the absence of the remainder of the protein [18,27]. A peptide
containing the amino acid sequence of the first extracellular loop
was also synthesized. A short helix was seen in the NMR
structure on each end of the peptide corresponding to portions of
the TM on either side of the loop. The interior of the loop also
contained an additional helix [28].3.3. The human cannabinoid receptor
The human cannabinoid 1 receptor is the receptor that binds
Δ9 tetrahydrocannabinol and is coupled to Gi/o. A 44-residue
peptide has been expressed containing the amino acid sequence
of the third cytoplasmic loop of this GPCR. The peptide is
biologically active, thereby exhibiting a similarity to the
behavior of peptide fragments from the cytoplasmic face of
rhodopsin. The solution structure of this peptide exhibits helix
at both ends of the peptide, corresponding to portions of the two
connected transmembrane helices. The peptide forms a turn in
detergent micelles [29] mimicking the turn found in the intact
protein. A peptide fragment corresponding to helix 8 of the
receptor was studied in the presence of DPC micelles and also in
SDS micelles and found to be predominantly helical [30]. The
putative helix 8 of the cannabinoid 2 receptor has also been
synthesized and the structure determined in DPC micelles and
in DMSO. In both environments an α-helix was observed [31].
3.4. The human cholecystokinin-2 receptor
The human cholecystokinin-2 receptor from the gastro-
intestinal tract and central nervous system binds cholecystoki-
nin in the extracellular face of the receptor. The third
extracellular loop of the cholecystokinin-2 receptor (residues
352–379), a GPCR, was synthesized and its structure
determined in detergent dodecylphosphocholine (DPC)
micelles by solution NMR. The ends of the two helices, 6 and
7, to which the loop is attached are seen as is the turn connecting
the helices [32]. Interactions between this third extracellular
loop and ligands have been probed by NMR and other
techniques exploiting the remarkable observation that the
peptide fragment corresponding to the third extracellular loop
forms a stable complex with the hormone [32–36].
3.5. Bradykinin B2 receptor
A 34-residue peptide fragment corresponding to the second
intracellular loop of the bradykinin B2 receptor was synthesized
and the structure determined by solution NMR. A helix–turn–
helix motif was observed, a repeating theme for peptide
fragments corresponding to loops of GPCRs. The N-terminal
helix and the C-terminal helix of this peptide fragment likely
corresponded to the ends of the transmembrane helices to which
this loop is attached. The structure of a portion of the C-
terminus of this receptor was examined using a fragment that
was expressed and stable-isotope labeled and contained
residues 309 to 366 of the receptor. Evidence for helical
structure corresponding to helix 8 of GPCRs was observed in
the structure of this fragment of the bradykinin receptor [37,38].
3.6. Neurokinin-1 receptor
The neurokinin-1 receptor is expressed in neural tissue and
binds neuropeptide substance P (SP). A peptide fragment of the
amino terminus of this protein was synthesized and the structure
determined in the presence of DPC micelles. Some helix was
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residue peptide corresponding to the third extracellular loop of
this GPCR was made and its structure determined by NMR,
showing a largely helical structure, consistent with a helix–
turn–helix motif [39]. A fragment corresponding to the second
extracellular loop also showed some helical content [40].
3.7. β-adrenergic receptor
The β-adrenergic receptor is a GPCR responsive to external
hormone levels. Peptide fragments of this protein, corresponding
to the third intracellular loop of the turkey receptor (residues 284
to 295), were synthesized and studied in lysophospholipid mi-
celles by solution NMR. The C-terminal region of this loop
region showed helical structure, likely corresponding to the
beginning of TM 6 [41]. What was originally called the fourth
cytoplasmic loop (between TM7 and the palmitoylation site(s) of
the GPCR) was also examined as a protein fragment,
corresponding to residues 345 to 359 of the turkey receptor. A
predominantly α-helical conformation was observed [42]. The
putative helix 8 region of the human β-adrenergic receptor was
examinedwith a peptide in detergent and inDMSO. In agreement
with the previous study on the turkey receptor, it was also found
to be helical. However in water the peptide was disordered [43].
3.8. Saccharomyces cerevisiae α-factor receptor
The Saccharomyces cerevisiae α-factor receptor is a G-
protein coupled receptor of yeast involved in mating. An
extensive set of studies of the structure of this protein through
the use of peptide fragments has been reported. Peptides
corresponding to all the TM of this 7TM transmembrane protein
were synthesized and some of the loops. Structures were
determined in organic solvent by NMR. All TM showed helical
structures and one of the loop peptides was also structured [44–
48]. The fragment approach has been stretched through the
study of a large fragment of this receptor containing the third
extracellular loop, the seventh transmembrane helix, and a
portion of the C-terminus [49]. This structure showed helical
components in all three portions of the receptor.
3.9. α2A adrenergic receptor
The second cytoplasmic loop of this receptor was studied
using a peptide fragment in DPC micelles. This peptide proved
to be predominantly helical [50].
3.10. Human adenosine A2a receptor
Structures of peptide fragments corresponding to all 7
transmembrane domains were determined and found to be
independently stable as helices [51].
3.11. V1A vasopressin receptor
The V1A vasopressin receptor couples to the αq/α11 G
proteins and activate phospholipase Cβ. The second cytoplas-mic loop, iC2, plays a critical role in this process. Accordingly, a
peptide fragment containing the sequence of iC2 was synthe-
sized, both as a linear peptide and with an extension to connect
the amino and carboxyl terminal ends, and both forms inhibited
hormone binding to the receptor. Both fragments adopted a
helix–turn–helix motif, consistent with a turn in the protein
connecting two transmembrane helices [52]. The structures of
both peptide fragments were very similar to the structure of the
corresponding loop on rhodopsin [53].
3.12. Thromboxane A2 receptor
The thromboxane A2 receptor binds the prostanoid,
thromboxane A2, and regulates smooth muscle function and
hemostasis. To obtain structural information about the extra-
cellular face of this GPCR that binds the prostanoid, peptide
fragments of the first and second extracellular loops were
synthesized. In each case, loop structures were obtained [54,55],
consistent with the connection of this fragment to two
transmembrane helices.
3.13. Rhodopsin
Rhodopsin is the prototypical GPCR, the first to be studied in
detail, and the first to have a crystal structure reported.
Rhodopsin is the photopigment of retinal rod cells and responds
to light, enabling black/white vision at low light levels. Peptide
fragments have been used to scan the entire sequence of the
protein to define local secondary structure throughout this
receptor. Fragments corresponding to loops (connecting two
transmembrane helices) of rhodopsin formed loops in solution
[53,56]. Fragments corresponding to the seven transmembrane
segments of rhodopsin formed helices [57–59]. Structure was
also observed in fragments containing the sequence of the
carboxyl terminal of the protein [16,60]. Of particular interest is
a recent report of the behavior of a fragment corresponding to
helix 8 (see below) of rhodopsin. This region was shown to be
non-helical in water while it was helical in the crystal structure.
Now it has been shown that this region of rhodopsin acts as a
conformational switch: a fragment corresponding to helix 8 was
helical only in the presence of membranes [61].
One question that arises is the extent to which structures of
receptor fragments reflect the secondary structure of the native
protein. This question has been directly addressed using
bacteriorhodopsin. A series of peptide fragments of the protein
were designed, each overlapping their neighbor in the sequence
by about 10 residues. Each fragment represented either a turn or
a transmembrane helix of bacteriorhodopsin. High-resolution
NMR structures were obtained from each fragment and the
structures were overlaid on the corresponding part of the X-ray
crystal structure. Good agreement was observed between helices
in the protein and the structures of the fragments, and turns in the
protein and the structures of the fragments [62,63]. Extensive
studies have led to the conclusion that when a fragment of a
membrane protein exhibits secondary structure, that structure is
similar to the structure in the intact protein. In the case where the
fragment is disordered, no conclusion can be drawn.
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fragments: will peptide fragments containing the sequences of
loops form loop structures without constraints on the position of
the amino and carboxyl termini? In some cases, loops naturally
formed with free amino and carboxyl termini (see for example,
[39,52]. In these cases, the residues in the turn likely directed
the form of the structure, perhaps enhanced by helix–helix
interactions when the structure was defined by a helix–turn–
helix motif. In some examples, β-turns formed which were
stabilized by internal hydrogen bonding [53]. In other cases,
covalently linking the two ends of the turn enhanced the
stability of the turn (see for example, [27,54]). Finally, structural
studies of loops in the presence of detergent micelles as a
membrane mimetic also stabilized the structures (see for
example, [39,50]). Perhaps less surprisingly, the peptide
fragments containing sequences of transmembrane helices of
GPCRs formed stable helices separate of the remainder of the
protein (see for example, [51,59]).
In companion experiments, it is possible to study fragments
of G protein binding to the relevant GPCR. One such example is
the binding of a peptide fragment of transducin (visual G
protein) to rhodopsin. NMR experiments defined the conforma-
tion and ultimately the orientation of this fragment when bound
to the active form of the receptor [64–66]. This places important
constraints on the structure of the complex of the G protein and
the receptor.
Although not GPCRs, it is worth noting that this approach to
membrane protein structure has been used with success by
investigators interested in other membrane proteins as well.
Structures of peptide fragments of the following proteins have
been determined and found to report on the secondary structure
of the parent protein: EmrE, a multidrug resistance protein [67],
the potassium ion channel [68], the human red cell anion
transporter, band 3 [69,70], the voltage-gated potassium
channel, Isk [71], bacteriorhodopsin [72–75], and human
erythrocyte glycophorin [76].
4. Interactions between transmembrane helices of GPCRs
The work described above on peptide fragments of GPCRs
derived from transmembrane segments of the protein revealed
that the transmembrane helices of GPCRs are intrinsically stable
in their helical secondary structure, a stability apparently arising
from their amino acid sequences. These results raise the
question of the role of helix–helix interactions in GPCRs. Early
experiments with a simple membrane protein, human erythro-
cyte glycophorin, identified some principles governing helix–
helix interactions in membrane proteins [76]. The transmem-
brane helix of glycophorin forms stable dimers in the
membrane. Glycines at the point of closest contact can be
important to that stability.
Helix–helix interactions have been discovered that con-
tribute to the stability of GPCRs. Co-expression of bundles of
transmembrane helices of rhodopsin (3 TM and 4 TM, or 5 TM
and 2 TM) can result in correct reassembly of the fragments into
a functional pigment [77]. This remarkable result identifies a
strong and specific interaction within the bundle of transmem-brane helices. Calorimetry has shown more quantitatively the
contribution of these interactions to rhodopsin stability [78].
Such helix–helix interactions were studied in detail for the
adenosine A2A receptor. These studies reported that helix
stability was enhanced in some cases by the presence of
neighboring helices during protein folding [79]. These authors
also found evidence for self-association of transmembrane helix
5, which could be part of the foundation for dimerization of
receptors [80].
These studies suggest that stability and folding of GPCRs are
influenced by several factors. The helical transmembrane
segments of GPCRs have considerable local stability and will
spontaneously fold, likely early in the folding process [81].
Helix–helix interactions are specific and strong as reflected in
the ability of separately expressed bundles of GPCR transmem-
brane helices to associate correctly. Loops connecting the
transmembrane helices in many cases exhibit intrinsic stability
and that also contributes to overall GPCR stability. Therefore
the stability of GPCRs is built from short-range intrinsic
stability of secondary structure (helices and turns) and from
helix–helix interactions within the membrane bilayer.
5. Modeling of GPCRs
Many groups have, over the years, reported various ap-
proaches to modeling GPCR structure driven by the lack of
experimental three-dimensional structural information. Most
of the early work was done modeling rhodopsin. After the
rhodopsin crystal structure was reported, modeling shifted to
other GPCRs, for which there are no X-ray crystal structures
at the time of this writing. A review of structure modeling for
GPCRs is beyond the scope of this review. However, some
of the milestones that informed this modeling and some of
the pitfalls are important to note. The latter add emphasis to
the need for experimental data on GPCR three-dimensional
structure.
The first transmembrane protein for which experimental
three dimensional structural information became available was
bacteriorhodopsin [82–84]. Bacteriorhodopsin was found to
consist of a bundle of 7 transmembrane helices, most
approximately perpendicular to the membrane surface. The
bundle of 7 TM attracted considerable interest for those
interested in GPCRs when it became clear that GPCRs also
were built around a bundle of 7 transmembrane helices. Many
investigators then used the helices of bacteriorhodopsin as a
template upon which to build models of rhodopsin. However, it
later became known that the arrangement of the transmembrane
helices in rhodopsin was not the same as the arrangement in
bacteriorhodopsin [85]. Therefore models of rhodopsin built on
the bacteriorhodopsin model could not be correct.
Subsequently, an advance in modeling GPCRs was provided
by a study from Baldwin [86], in which the available knowledge
from sequence and homology was utilized in conjunction with
some important new principles for membrane protein structure
to produce a model for rhodopsin. Those principles included:
conserved residues likely faced other protein surfaces rather
than the lipid bilayer and residues with some polar character
Fig. 2. Orientation of retinal in ground state rhodopsin, from 1U19 [176]. Retinal
shown in red. Figure prepared from VMD [177].
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Combination of such principles with the hydrophobicity plot of
rhodopsin allowed a packing of the transmembrane helices in a
bundle. This model ultimately proved to be remarkably accurate
in its predictions. Using Baldwin's model and some available
experimental constraints, a molecular model of the transmem-
brane helical bundle was developed [87] that ultimately was in
reasonable agreement with the X-ray crystal structure. More
recent modeling on rhodopsin has explored the use of a wider
range of experimental distance constraints to drive the modeling
process. This has led to models of metarhodopsin II [88], for
example, with considerable detail and with a close correspon-
dence to the experimental approach described above using
sparse constraints for structure determination.
More recently, many new modeling approaches have been
developed to expand modeling from rhodopsin to other GPCRs
(see for example, [89–91]). These have relied on the assumption
that all GPCRs have similar structures in the transmembrane
domain [92]. Comparisons among rhodopsins provide some
justification for this assumption, but also some caution [85].
While the arrangement of the transmembrane helices of bovine,
frog, and squid rhodopsins are similar, they are not identical.
Therefore some care would be appropriate in extrapolating the
arrangement of transmembrane helices in rhodopsin to other
members of the rhodopsin family of GPCRs. Even greater care
would be warranted if one extrapolated the structure of
rhodopsin to the modeling of GPCRs outside the rhodopsin
family.
6. Structure studies of retinal binding to rhodopsin
The most detailed structural studies of ligand binding to
GPCRs have been of retinal bound as a Schiff base in
rhodopsin, but it should be noted that there is a large literature
of retinal bound to bacteriorhodopsin, an early example of
which was performed utilizing neutron diffraction [93].
However this review is focused on GPCRs and therefore will
be unable to examine that literature more carefully. And while
studies on retinal bound to rhodopsin could be the subject of a
review in itself, nevertheless a synopsis of some of that work
will be reviewed below as it relates to structure of GPCRs.
NMR, particularly solid state NMR, has proven particularly
valuable in the study of retinal bound to rhodopsin. As is now
well known, retinal is bound as a Schiff base to K248 on TM7 of
rhodopsin. The state of protonation of the Schiff base has been
the subject of NMR studies with early solid state 13C NMR
studies of 13C labeled retinal and the data were consistent with a
protonated Schiff base [94], in agreement with previous
spectroscopic studies [95].
How retinal fits into its binding site in rhodopsin was rather
completely worked out without the X-ray crystal structure.
Retinal as a ligand can be removed from rhodopsin and
replaced, and rhodopsin regenerated. Regeneration allows the
incorporation of retinal into rhodopsin that has been artificially
labeled with stable, NMR-sensitive isotopes. 13C- and 2H-
labeled retinals were both used in solid-state NMR experiments
that allowed the visualization of resonances from the retinal inthe binding site in the protein that in normal high resolution
experiments would be too broad to be observed. These
experiments are largely done at low temperature, both to trap
the appropriate state of the receptor and to defeat motional
damping that would otherwise obscure the resonances at
physiological temperature.
Several groups have contributed studies using this experi-
mental approach. While they do not all agree in every aspect,
nevertheless they collectively provide considerable detail on the
arrangement of the ligand, retinal in this case, in the protein. The
published studies primarily explore rhodopsin.
The orientation of retinal in the protein, relative to the normal
of the bilayer, was determined by 2H NMR of specifically
deuterated retinal with which the rhodopsin had been
regenerated [96]; later studies extended this understanding of
retinal positioning in the protein [97]. Computational studies
synthesized the NMR data into a consensus orientation [98].
This orientation of the retinal later proved to be largely
confirmed by the X-ray crystal structure. Such agreement
provides a basis for using the same approach in the study of
ligands bound to other receptors. The orientation of the retinal is
presented in Fig. 2 from the crystal structure of rhodopsin.
Other studies with solid state 13C NMR of 13C labeled
retinals in rhodopsin have provided insight into the photo-
chemistry of this ligand. 11-cis retinal photoisomerizes to all-
trans retinal upon absorption of a photon of light. In ways not
yet fully understood (see Activation of rhodopsin below), that
isomerization is transmitted to the protein such that the
conformation of the cytoplasmic face of the protein changes
significantly and binds the G protein. (For other GPCRs, the
binding of the ligand induces the analogous conformational
change.) Therefore both the conformational response of the
retinal and the interactions between the retinal and the protein
are of great importance. The H–C10–C11–H torsional angle of
the retinylidene chromophore in rhodopsin was determined to
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[99]. 13C chemical shifts strongly reflect electron distribution in
the molecule and are particularly sensitive in a highly
unsaturated ligand like retinal. Those 13C chemical shifts reveal
how amino acid residues on the protein that interact with the
retinal perturb the retinal structure. An example can be seen in
one study of a perturbation in the vicinity of position 13 [100].
The retinal electronic study is strongly influenced by the
proximity of counterions to the Schiff base. The latest theories
suggest a counter-ion switch: E113 is the ground state
counterion [101], but during the photocycle there is a switch
to E181 [102,103]. Changes in the position of these charges
relative to the conjugated double bonds of the retinal changes
the electronic structure of the molecular orbitals and thus the
character of the absorption of light.
Other studies provided insight into other contacts between
the retinal and the protein. For example, using a uniformly 13C
labeled retinal and solid state NMR, interactions between the
retinal and F208, F212, and W265 were discovered [104]. The
W265 interaction with C20 of the retinal was suggested to
stabilize the ground (inactive) state of rhodopsin [105]. Another
solid state NMR study found interactions between Y268 and
Y191 and retinal in the binding site [106]. As will be seen later
some of these interactions changed after photoexcitation.
7. Structural studies of ligand binding to GPCRs
A number of other studies have been reported on the nature
of other ligand binding sites on other GPCRs. The richness of
the structural information obtained from studies of peptide
fragments of membrane proteins stimulated some investigators
to push further by posing questions of ligand binding to the
receptors. This requires reconstruction of a face of a receptor
from the constituent loops. One early example was a
reconstruction of the cytoplasmic face of rhodopsin [107].
However, for ligand binding, the extracellular face must be
reconstructed, in part or in whole, in the presence of the relevant
ligand. Several successful examples have been reported of such
ligand–receptor binding, including binding of ligand to the
thromoxane A2 receptor [108], substance P binding to the
neurokinin-1 receptor [39], and cholecystokinin-8 binding to
the cholecystokinin A receptor [35,36,109]. These are very
interesting studies in that they imply that structural features of
the binding sites are preserved in peptide fragments of the
protein; in particular peptide fragments of the extracellular face
of the receptor. In each case, the affinity of the ligand for the
peptide fragments is sufficient to enable inter-molecular NOEs
to be observed that define the contact points between the
fragments and the ligand.
8. Diffraction studies of 2D crystals of ground state
rhodopsin
The goal of the structural studies is ultimately a three dimen-
sional picture of the complete structure of the GPCR. This re-
quires studies of the intact protein. Rhodopsin was the first
GPCR to be studied in this fashion because it is the only GPCRthat can be readily obtained from tissues in high abundance
[110]. Although many attempts have been made to obtain crys-
tals from a wide range of GPCRs, the only successful structural
studies to date are of rhodopsin. The following will review the
progress, starting with two-dimensional crystals of rhodopsin.
Following the success of Henderson's structure analysis of
bacteriorhodopsin in two dimensional crystals [111], early
efforts were devoted to developing two dimensional crystals for
bovine rhodopsin. The first projection density map for
rhodopsin from such two dimensional crystals appeared in
1993 using cryo-electron microscopy [9]. In this map at 9 Å
resolution, four regions of well-defined density suggested four
transmembrane helices roughly perpendicular to the membrane
surface. In addition an arc of unresolved density suggested the
location of the remaining three transmembrane helices that were
not perpendicular to the membrane surface. As mentioned
above, this was critical early evidence for the now well-known 7
transmembrane helical bundle that is the structure around which
all GPCRs are likely built.
Schertler took the lead on development of this approach for
rhodopsin and progressed by 1995 to a low resolution three
dimensional map for bovine rhodopsin [112]. The resolution in
the plane parallel to the presumed membrane surface was 9.5 Å
and in the plane perpendicular the resolution was about 47 Å.
Even with this low resolution, it was now possible to trace several
of the transmembrane helices in the transmembrane bundle. At
this point it also became clear that the arrangement of the helices
was different than reported earlier for bacteriorhodopsin. There-
fore while the motif of 7 transmembrane helices was similar
between bacteriorhodopsin and rhodopsin, the structure of the two
proteins was significantly different. The resolution of this
approach was improved with new crystals in 1998 [113].
In concert with these studies on bovine rhodopsin, a report was
published on frog rhodopsin that showed the preservation of the
configuration of the 7 transmembrane helices from one species to
another [114]. An improved picture of the disposition of the
helices perpendicular to the membrane surface was obtained and
the tilt of helix 3 within the transmembrane bundle became
apparent. Another species was added in 1996, squid rhodopsin
[85]. At this point, it was possible to compare rhodopsin from
three different species and conclude that the arrangement of
transmembrane helices was similar in all three species.
Analysis of two-dimensional crystals held a singular
advantage over the studies of three-dimensional crystals to
follow; the two-dimensional crystals were derived from
membrane structures containing lipid. Therefore the resulting
structure reflects the influence of the lipid bilayer on structure
and likely offers a more accurate view of receptor structure. The
singular disadvantage of the two dimensional crystal studies
was the relatively low resolution that characterized the 2 and 3
dimensional projection maps.
The resolution from the two-dimensional crystals was
improved to 5.5 Å in the plane parallel to the surface of the
membrane and 13 Å perpendicular to that plane [115]. This
structure identifies unambiguously the orientation of ground
state rhodopsin relative to the membrane, information that is not
available from the three dimensional crystal structures.
816 P.L. Yeagle, A.D. Albert / Biochimica et Biophysica Acta 1768 (2007) 808–8249. Diffraction studies of 3D crystals of ground state
rhodopsin
The studies just reviewed utilizing electron diffraction of two
dimensional crystals of ground state bovine rhodopsin provided
critical new information on the arrangement of the transmem-
brane helices of rhodopsin, but no information on the
disposition of the ligand, retinal, or the individual amino acids
in the protein. That information awaited the development of
three-dimensional crystals of rhodopsin.
In 2000, Okada et al. reported the first diffraction from three
dimensional crystals of rhodopsin suitable for high resolution
structure determination (see Fig. 3) [116]. This was quickly
followed by a full analysis providing the first high resolution
three dimensional structure of a GPCR to 2.8 Å [13]. It is fair to
say that this report of the structure of bovine rhodopsin
completely changed the GPCR field. In this structure, the seven
transmembrane helices could be traced fully. Many, though not
all, of the loops were identified. The C-terminal region was
largely undefined, except for a somewhat surprising helix,
called helix 8, appearing at right angles to transmembrane helix
7 (to be discussed further below). At the end of helix 8, the
palmitoylation sites are found. The amino terminus, which
contains the covalently attached carbohydrate, forms some β-
structure that appears to cover the retinal binding site. The
retinal can also be seen, bound as a Schiff base to K248 on
transmembrane helix 7 and extending roughly parallel to the
putative membrane surface through the bundle of 7 transmem-
brane helices. The interactions of amino acid side chains with
the retinal can be seen, including W265 interacting near the β-
ionone ring and the counter ion to the Schiff base, E113, all of
which were implicated by other experiments as described
above. What came to be termed the ionic lock, between R135
(of the highly conserved D(E)RY sequence at the end of helix 3)
and E247 on helix 6 [117,118], can be seen in the crystalFig. 3. Crystal structure of ground state rhodopsin from 1U19 [176]. Figure
prepared from VMD [177].structure and stabilizes the ground state of rhodopsin. This
wealth of structural information from the first crystal structure
of bovine rhodopsin stimulated a wide range of studies.
Improvements in this structure determination have been
reported. The resolution from the three-dimensional crystals
was improved to 2.6 Å [119]. A new crystal form was recently
reported for rhodopsin at 2.65 Å resolution and the structure
was in good agreement with the other crystal structures [120].
These reports were followed by further improvement to 2.2 Å
[121]. This higher resolution structure revealed more details
about the binding of the retinal and the twisted conformation in
the inactive ground state of rhodopsin.
10. Three-dimensional structures from sparse constraints
The structural detail for inactive rhodopsin has proven to be
exceptionally important to advancing mechanism studies in the
field of GPCRs. However, the limitation is that the structure for
only one GPCR has been yet solved. With the wide range of
cellular functions controlled by GPCRs, structural information
for some of the remaining hundreds of GPCRs is very much
needed. Therefore an important question is whether there are
other ways to obtain three-dimensional structures for GPCRs,
based solely on experimental data and not on modeling.
A study published in 2001 suggested the answer to that
question was “yes”. In that report, the structure of bacteriorho-
dopsin was solved, based on experimental data only, without
either two-dimensional or three-dimensional crystals [63]. The
approach was based in part on the use of sparse constraints. The
use of sparse constraints will first be discussed, followed by a
discussion of the use of such an approach for GPCRs.
Another such approach using sparse constraints employed a
two-step approach to obtaining a structure. First a basis set of
14 crystal structures already reported for integral membrane
proteins built around helical bundles was analyzed. Informa-
tion concerning helix packing was obtained. Second a set of
experimental distance constraints was identified from pub-
lished experiments utilizing a variety of techniques sensitive to
distance within the GPCR (these will be described below in
more detail). Third a penalty function was developed to drive
simulated annealing of a model towards a structure that
satisfies all the experimental distance constraints. With this
approach, only 27 experimental distance constraints were
required to produce a structure for rhodopsin with an RMSD
of 3.2 Å relative to rhodopsin for the transmembrane domain
(assuming that the transmembrane segments were helices)
[122].
Girvin et al. exploited 99 experimental distance constraints
from the integral membrane protein, lactose permease, many
from the laboratory of Kaback, to produce a structure of the
transmembrane domain of this protein [123]. The experimental
distance constraints defined inter-helical site-to-site distances in
the 12 transmembrane helices that constitute the transmembrane
domain of this transporter. The model was subjected to
simulated annealing with distance constraints and the resulting
structure agreed with the experimental site-to-site distances.
This work also assumed that the transmembrane segments were
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the transmembrane region could be defined in this manner.
The structure determination for bacteriorhodopsin noted earlier
avoided one of the assumptions of the previously described two
studies on rhodopsin and lactose permease. In the bacteriorho-
dopsin study, the conformation of the transmembrane segments of
the protein were defined by solution structure determinations of
synthesized peptide fragments using high-resolution NMR
techniques. Furthermore, the conformation of the loops connecting
the helices were determined by NMR using peptide fragments as
well. All the peptide fragments (13) overlapped their neighbors in
the sequence in a helical region, so that the fragment structures
could be linked by superposition of the overlapping regions. This
process defined the full secondary structure of the protein (details
of this approach to defining secondary structure were presented in
the early part of this review). Then inter-helical experimental
distance constraints were introduced and simulated annealing was
used to produce a structure that satisfied all the available distance
constraints: a limited set of interhelical distances characterizing the
packing of the helices, and a much more extensive set of NOE-
based distance constraints characterizing all the secondary
structure of the protein. The assumption in this approach is that
the secondary structure in the fragments is the same as in the intact
protein. Direct comparisons with known crystal structures of
bacteriorhodopsin confirmed that this assumption was valid. The
resulting structure showed an RMSD with respect to the
bacteriorhodopsin crystal structures of 2.9 Å for the transmem-
brane domain [63]. This fit is not far from the RMSD
characterizing comparison of one crystal structure with another
from different structure determinations of bacteriorhodopsin. This
result indicated that valuable structural information could be
obtained from sparse distance constraints and secondary structure
determination by NMR from peptide fragments of the protein for
proteins built around helical bundles (this approach would not be
expected to be useful for membrane proteins built on β-structures
such as the β-barrels of the porins).
The success of the above studies provided the basis for an
alternate structure determination for bovine rhodopsin.
Step 1. Following the pattern with bacteriorhodopsin, a set of
overlapping peptide fragments of rhodopsin that
spanned the full sequence of the protein was synthe-
sized and their structures determined by high resolution
NMR. These peptide fragments formed helices or turns
for the most part [16,53,56–58,60,107,124].
Step 2. A set of site-to-site experimental distance constraints
was harvested from a rich literature of such experiments
for bovine rhodopsin (see below).
Step 3. A starting model was prepared by superimposing the
overlaps of the peptide fragments. To this model all the
distance constraints from step 1 (NOEs) and step 2 were
written on the model. This construct was then subjected
to simulated annealing and a structure obtained that
satisfied all the distance constraints from step 1 and 2.
The result of this process was a structure for ground state
bovine rhodopsin [125]. This structure exhibited an RMSDwiththe first crystal structure of rhodopsin of 1.85 in the trans-
membrane region, indicating good agreement. This structure
provides complementary information relative to the crystal
structure in that the cytoplasmic face of the receptor, which
couples with the G protein, is defined in this structure and the
cytoplasmic face is partly undefined in the crystal structure.
This approach has applicability to structure determinations of
other GPCRs and to other integral membrane proteins built
around transmembrane helical bundles. The site-to-site dis-
tances are obtained from a variety of experimental measure-
ments. The richest set of such distances were obtained through
site-directed spin labeling in which dipolar interactions between
two spin labels at known sites were interpreted in terms of
specific distances [126–143]. Another set of experimental
distances can be inferred from disulfide bond formation [144–
147]. Yet another distance constraint could be inferred from
engineering a metal binding site [148], another from spin label–
nuclei dipolar interactions [149] and another from dipolar
interactions between fluorine nuclei [150]. In addition in cases
where low-resolution projection maps are available for the
protein, adequate interhelical distances can be obtained to
support this structure determination.
These results were recently exploited to study the structure of
the thromboxane A2 receptor. As in the case of rhodopsin
described above, the solution structures of peptide fragments
containing loops of the receptor were solved by NMR and these
structures were assembled into a structure of the whole protein.
For the transmembrane region of this protein, a model based on
rhodopsin was used [108]. These results suggest that this
approach to GPCR structure will be useful into the future, in
the absence of readily obtained crystals suitable for X-ray
crystallography.
11. Activation of rhodopsin
All the structural studies described above provide informa-
tion about the structure of the inactive form of the GPCR,
rhodopsin. The mechanism of activation of a GPCR is of intense
interest. As before, the greatest depth of information is for
bovine rhodopsin and this will now be discussed.
Rhodopsin, once excited by light, cycles through a series of
spectral intermediates that produce metarhodopsin I. During
this process as currently understood, nearly all the changes in
the receptor are confined to the ligand with few changes in the
protein structure. It is only upon moving to metarhodopsin II,
the next step after metarhodopsin I that the receptor becomes
active, the conformation changing such that the receptor can
bind the G protein and activate it. A recent electron crystal-
lographic structure with a predominance of receptors in the meta
I form shows that the protein structure changed little from the
inactive ground state rhodopsin [151]. The retinal underwent
some change including a change in the twist seen in the ground
state, but even though the retinal is less twisted in the
metarhodopsin-I state [99], the conformation of the β-ionene
ring was similar to the conformation seen in the ground state
[152]. As the authors of the crystal structure report point out,
there is no gradual, step-by-step change in the conformation
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that the action is focused on the retinal through much of the
photocycle [97] and by some process yet to be described, the
energy confined to the retinal after isomerization is conveyed to
the protein concurrent with the conformational change from
metarhodopsin I to metarhodopsin II.
This raises the question: what is the conformation of
metarhodopsin II? That question needs to be answered before
the mechanism of activation of G protein can be addressed. No
crystal structure has yet been reported for metarhodopsin II.
Light induces damage to the crystals of rhodopsin [116],
indicating that light is inducing a conformational change in the
protein, but no usable crystals of metarhodopsin II have been
reported. However, many experiments have been reported that
add individual details to the understanding of what changes
when metarhodopsin II forms. Some of those experiments will
be recounted here.
The ligand, retinal, changes position in the protein upon
activation to metarhodopsin II. The retinal translates in the
helical bundle in the direction of TM5 with a concomitant
rotation of the C-20 group of retinal [153]. Consequently the
contact between C-20 of the retinal and W265, found in the
ground state, is lost and a contact of W265 with the C19 methyl
group is substituted [105]. The ring of the retinal was reported to
contact helix 4 of rhodopsin upon activation, a contact that is
not possible in the ground state structure [154].
The powerful approach of site-directed spin labeling
provides important site-to-site distances within the helical
bundle of the GPCR. From such experiments, investigators
have discovered that the helices in the transmembrane domain
change their orientation relative to each other when metarho-
dopsin II is formed. For example, TM2 of rhodopsin moves
relative to helix 8 upon activation to metarhodopsin II [155], as
does TM6 [141]. The movement of TM6 was described as a
rigid body movement [129]. However, studies of the influence
of prolines on helix conformation indicated that the helical
segments on either side of the proline can swivel with respect to
each other and this can be a source of some of the
conformational changes seen in the transmembrane domain
[156,157]. TM7 and TM1 become further separated [142] upon
activation. A caution in the interpretation of these inter-site
distances is in order. These site-directed spin label experiments
produce approximate distances between sites (with an uncer-
tainty derived from the length of the spin label and its position).
When changes in the distances occur, one cannot say with
certainty whether one or both of the helices (to which each of
the two spin labels are attached) moves; only that the distance
between them changes.
Structural changes mediated by membrane phospholipids
may also play a role in activation. The region of helix 8 is
dependent on membranes: it is helical in the presence of
membranes and is non-helical in the absence, as described in the
discussion of fragments of rhodopsin. Phosphatidylserine
content in the membrane particularly stabilizes the helical
form [61]. Many years ago it was reported that phosphatidyl-
serine in the disk membrane has a special relationship with
rhodopsin, apparently binding to the receptor [158].Data such as those derived from site-directed spin labeling,
provide some of the few details known about the structural
changes that occur in the protein upon activation to metarho-
dopsin II. Employing the same approach used to successfully
determine a structure for ground state rhodopsin from sparse
distance constraints, a structure for metarhodopsin II was
reported [159]. This structural determination exploited the
changes in distances from site-directed spin labeling to define
the structural changes that occurred in three dimensions when
metarhodopsin II was formed. The success that attended the
determination of ground state rhodopsin calls for a closer look at
what this structure can report on the conformational change that
results from activation of this GPCR.
The greatest density of long-range distance constraints were
in the cytoplasmic face of the receptor, so that is the region that
should be examined more closely, and is of considerable interest
since it is the surface that couples to the G protein. The most
obvious change that occurs in the cytoplasmic face of this
receptor is the opening of a cleft in the surface. This results from
a breaking of the ionic lock between R135 (of the highly
conserved D(E)RY sequence at the end of helix 3) and E247 on
helix 6. This ionic interaction stabilizes the ground state and
apparently must be broken to form the excited state. The cleft
that appears is an obvious candidate for interaction with
portions of the G protein, as had been suggested previously
[160]. Using recent studies on fragments of the G protein
binding to metarhodopsin II [65] and the structure derived for
metarhodopsin II [159], as well as other experimental clues to
the interface, a model for binding of the G protein, transducin, to
metarhodopsin II was described [161]. The hypothesis was
advanced that the G protein bound through an induced fit
mechanism in which the binding energy of transducin to
metarhodopsin II was utilized to induce a conformational
change in the G protein.
Another report [162] offered a model for the activated state
of rhodopsin that also utilized some of the same experimental
data as the study described above. The approach was somewhat
different, but still employed a simulated annealing to achieve a
structure that satisfied the distance constraints characteristic of
the metarhodopsin II state. Interestingly this determination
began with the crystal structure of the ground state and
perturbed that structure with the distance constraints of the
excited state. In agreement with the previous structure [159], the
salt bridge between R135 and E247 was broken and helix 7
kinks upon activation. As well, a large change in position of
helix 8 was noted.
An alternative approach to the definition of the structure of
the cytoplasmic face of metarhodopsin II used antibodies that
recognized the difference in conformation of the surface
between the inactive and activated receptor. Unique antibodies
were obtained that stabilized either metarhodopsin I or
metarhodopsin II. By identifying the epitopes recognized by
these antibodies, the authors concluded that conformational
changes occurred in the cytoplasmic face between the two forms
of the receptor. In particular, their data suggested changes in the
C-terminus of the protein, the third cytoplasmic loop and helix 8
[163]. One of these antibodies (K42-41L) and its epitope were
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epitope that was recognized by K42-41L likely was not
available for binding in metarhodopsin II. Using a peptide
(TGALQERSK) that mimicked the binding of the epitope to the
antibody, the structure of the peptide bound to the antibody was
determined, and, presuming that this conformation reflected the
conformation on the surface of the receptor, concluded that the
third cytoplasmic loop changed conformation upon activation
[164]. This conclusion was consistent with the conformational
changes observed in the two structures described above for
metarhodopsin II. In this regard, the observation that loops from
the cytoplasmic face of rhodopsin have been fused with
thioredoxin in a configuration that successfully activated the
G protein, transducin, indicated that the loops could form a
surface with the binding site for the G protein as well [165].
Apparently there is considerable local stability in some of the
loops.
12. Activated states of non-rhodopsin GPCRs
Limited information is available on the structures of the
excited state of other GPCRs. A few examples will be given,
though there is not much detail on any one receptor. Work on
the CB1 receptor implicated structural changes in the third
cytoplasmic loop [166], parallel to the conclusions for
rhodopsin. Echoing what was described above, swivels enabled
by prolines were implicated in the conformational changes
characterizing the activation of the human prostacyclin receptor
[167]. In particular a proline in helix 3 was found to be
necessary for the transition to the active state of the receptor. A
study on the angiotensin II receptor found an alteration in
conformation involving TM2 in a constitutively active receptor
[168]. Their data also implicate a change in the interaction
between TM2 and TM7 upon activation [169]. Disulfide
crosslinking studies have been used to probe conformational
changes upon activation of the muscarinic acetylcholine
receptor and the data suggested a structural change in the
interaction between TM5 and TM6 at the cytoplasmic end as
well as an alteration of the helix structure of helix 6 at the end
close to the cytoplasmic face [170]. Interestingly, NMR data
previously indicated that the cytoplasmic end of TM6 is
relatively unstable as a helix [125].
13. Unresolved structural issues
Although a great need continues for new structural
information of GPCRs, there is an as yet unresolved issue
among the published reports that may have importance to the
activation process for some GPCRs. Helix 8 is a helix that
extends at approximately a right angle from the end of TM7 to
the palmitoylation sites in the crystal structure of rhodopsin.
This helix has been seen in peptide fragments of other receptors
as well [20,31,37,38,42,43,171]. Although many structural
changes occur involving helix 8 upon activation, its conforma-
tion in metarhodopsin II is as yet uncertain. It has been
suggested that a significant conformational change, destabiliz-
ing helix 8, may occur upon activation of rhodopsin [21]. Thissuggestion is supported by studies on peptide fragments of the
carboxyl terminus of rhodopsin that show no intrinsic
propensity for the helix 8 segment to form a helix spontaneously
in solution [172]. Recent molecular dynamics studies show
stability of this segment in the presence of a lipid bilayer [173].
It is particularly noteworthy that in both rhodopsin [21,61,174]
and in the angiotensin II receptor [171] the structure of this
portion of the carboxyl terminus is sensitive to the lipid content
of the bilayer, in particular the presence of anionic phospho-
lipids. These data collectively indicate that this portion of the
protein may be conformationally flexible depending upon the
state of the proteins and may offer a point of conformational
modulation influenced by the lipid bilayer.
A second unresolved issue is the conformation of the
carboxyl terminus of rhodopsin. FTIR studies suggested the
presence of some limited β-structure in the carboxyl terminus
[175] and in agreement, studies of the C-terminus by NMR
revealed some modest β-structure amongst a reasonably well-
ordered fragment of the receptor [16,60]. Yet experiments from
site-directed spin labeling in the carboxyl terminus suggested
that the carboxyl terminus was largely disordered [132]. The X-
ray crystal structures do not have sufficient order in that region
of the protein to resolve the issue.
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